Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 USD | +5.22% | +0.83% | -5.10% |
30/04 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
30/04 | Top Premarket Gainers | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The company is in debt and has limited leeway for investment
- With an enterprise value anticipated at 4.01 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.10% | 611M | - | ||
+5.80% | 2,957B | C+ | ||
+1.64% | 79.84B | B | ||
+1.50% | 75.23B | B+ | ||
-17.08% | 51.63B | B+ | ||
+31.33% | 50.22B | D+ | ||
-22.83% | 47.78B | B- | ||
+22.46% | 43.07B | D+ | ||
+57.98% | 36.75B | D+ | ||
-11.11% | 24.41B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BLND Stock
- Ratings Blend Labs, Inc.